Your shopping cart is currently empty

UH15-38 is a potent and selective RIPK3 inhibitor that blocks necroptosis in alveolar epithelial cells triggered by IAV, useful for studying lung inflammation.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $123 | In Stock | In Stock | |
| 5 mg | $297 | In Stock | In Stock | |
| 10 mg | $496 | In Stock | In Stock | |
| 25 mg | $993 | In Stock | In Stock | |
| 50 mg | $1,590 | In Stock | In Stock | |
| 100 mg | $2,550 | - | In Stock |
| Description | UH15-38 is a potent and selective RIPK3 inhibitor that blocks necroptosis in alveolar epithelial cells triggered by IAV, useful for studying lung inflammation. |
| Targets&IC50 | RIPK3:20 nM |
| In vitro | UH15-38 significantly reduces the incidence of necrosis within type I alveolar epithelial cells (AEC), thereby minimizing the pro-inflammatory environment in the lungs. [1] |
| In vivo | In mouse models of severe IAV infection, UH15-38 significantly inhibited lung damage. By inhibiting RIPK3-MLKL signaling, it reduced the number of necrotic cells within the lung parenchyma, particularly type I AECs, without affecting the frequency of apoptotic cells. [1] |
| Molecular Weight | 441.53 |
| Formula | C26H27N5O2 |
| Cas No. | 2540881-21-6 |
| Smiles | O=C1C(=CC=2C=NC(=CC2N1C)NC3=CC=CC(=C3)N4CCN(C)CC4)C5=CC=CC(O)=C5 |
| Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (181.19 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (11.32 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.